Hansen Medical (NASDAQ: HNSN) and Presbia (NASDAQ:LENS) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.
Institutional and Insider Ownership
16.1% of Presbia shares are held by institutional investors. 74.7% of Presbia shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
This is a breakdown of recent recommendations for Hansen Medical and Presbia, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Presbia has a consensus price target of $9.67, suggesting a potential upside of 174.62%. Given Presbia’s higher possible upside, analysts plainly believe Presbia is more favorable than Hansen Medical.
Earnings & Valuation
This table compares Hansen Medical and Presbia’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
Hansen Medical has higher earnings, but lower revenue than Presbia. Presbia is trading at a lower price-to-earnings ratio than Hansen Medical, indicating that it is currently the more affordable of the two stocks.
This table compares Hansen Medical and Presbia’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Presbia beats Hansen Medical on 7 of the 10 factors compared between the two stocks.
About Hansen Medical
Hansen Medical, Inc. is engaged in the development and marketing of medical devices. The Company develops, manufactures and sells a range of medical robotics designed for positioning, manipulation and stable control of catheters and catheter-based technologies. Its products include Sensei Robotic Catheter System (Sensei system), Artisan Extend Control Catheter, CoHesion 3D Visualization Module and Magellan System. Its Sensei system allows physicians to navigate catheters in interventional procedures within the atrial heart chambers. Its disposable Artisan Extend catheter assembly consists of a telescoping set of control catheters. Its CoHesion 3D Visualization Module is a software interface between its Sensei system and the St. Jude Medical EnSite System for Electro-Physiology procedures. The Magellan System controls the Magellan Robotic Catheter, which is a telescoping, steerable catheter designed to facilitate remote catheter navigation and vessel cannulation.
Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. The Company’s segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States. The Company’s lens, referred to as the microlens, is a miniature lens designed to be surgically implanted in a patient’s eye to improve that patient’s ability to see objects at close distances. The microlens is a disc shaped lens that has a refractive zone in the periphery designed to improve near vision problems associated with presbyopia and a central zone that is designed to improve distance vision. The Company’s solution is a standalone solution for plano presbyopes, or those individuals suffering from presbyopia but do not have any other visual disorders.
Receive News & Ratings for Hansen Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hansen Medical and related companies with MarketBeat.com's FREE daily email newsletter.